Actively Recruiting
Collection of Circulating Biomarkers in Pancreatic Cancer
Led by Abramson Cancer Center at Penn Medicine · Updated on 2026-04-07
30
Participants Needed
1
Research Sites
254 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This protocol will involve collection of blood samples from patients with a diagnosis of pancreatic adenocarcinoma for evaluation of circulating biomarkers.
CONDITIONS
Official Title
Collection of Circulating Biomarkers in Pancreatic Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Known or presumed diagnosis of pancreatic adenocarcinoma
- Patient of the University of Pennsylvania
- Able to provide informed consent
- 18 years of age or older
You will not qualify if you...
- Any clinically significant psychiatric, social, or medical condition that could increase risk, interfere with study adherence, or affect ability to give informed consent, as determined by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Abramson Cancer Center at University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
Actively Recruiting
Research Team
L
Liudmila Mazaleuskaya, PhD
CONTACT
M
Mark O'Hara, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here